 Viral Envelope Proteins
"Viral Envelope Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Layers of protein which surround the capsid in animal viruses with tubular nucleocapsids. The envelope consists of an inner layer of lipids and virus specified proteins also called membrane or matrix proteins. The outer layer consists of one or more types of morphological subunits called peplomers which project from the viral envelope; this layer always consists of glycoproteins.
| Descriptor ID |
D014759
|
| MeSH Number(s) |
D12.776.964.970.880
|
| Concept/Terms |
Viral Envelope Proteins- Viral Envelope Proteins
- Proteins, Viral Envelope
- Virus Envelope Proteins
- Envelope Proteins, Virus
- Proteins, Virus Envelope
- Envelope Proteins, Viral
|
Below are MeSH descriptors whose meaning is more general than "Viral Envelope Proteins".
Below are MeSH descriptors whose meaning is more specific than "Viral Envelope Proteins".
This graph shows the total number of publications written about "Viral Envelope Proteins" by people in this website by year, and whether "Viral Envelope Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 4 | 0 | 4 | | 1994 | 1 | 1 | 2 | | 1996 | 1 | 2 | 3 | | 1998 | 0 | 2 | 2 | | 2001 | 0 | 1 | 1 | | 2004 | 4 | 1 | 5 | | 2005 | 0 | 2 | 2 | | 2006 | 4 | 0 | 4 | | 2007 | 1 | 0 | 1 | | 2008 | 1 | 0 | 1 | | 2009 | 1 | 0 | 1 | | 2010 | 3 | 0 | 3 | | 2011 | 2 | 0 | 2 | | 2012 | 3 | 1 | 4 | | 2013 | 2 | 3 | 5 | | 2014 | 2 | 0 | 2 | | 2015 | 1 | 0 | 1 | | 2016 | 1 | 2 | 3 | | 2017 | 0 | 1 | 1 | | 2018 | 1 | 1 | 2 | | 2019 | 3 | 0 | 3 | | 2020 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Viral Envelope Proteins" by people in Profiles.
-
Powell LA, Fox JM, Kose N, Kim AS, Majedi M, Bombardi R, Carnahan RH, Slaughter JC, Morrison TE, Diamond MS, Crowe JE. Human monoclonal antibodies against Ross River virus target epitopes within the E2 protein and protect against disease. PLoS Pathog. 2020 05; 16(5):e1008517.
-
Bubak AN, Como CN, Coughlan CM, Johnson NR, Hassell JE, Mescher T, Niemeyer CS, Mahalingam R, Cohrs RJ, Boyd TD, Potter H, Russ HA, Nagel MA. Varicella-Zoster Virus Infection of Primary Human Spinal Astrocytes Produces Intracellular Amylin, Amyloid-ß, and an Amyloidogenic Extracellular Environment. J Infect Dis. 2020 03 16; 221(7):1088-1097.
-
Carpentier KS, Davenport BJ, Haist KC, McCarthy MK, May NA, Robison A, Ruckert C, Ebel GD, Morrison TE. Discrete viral E2 lysine residues and scavenger receptor MARCO are required for clearance of circulating alphaviruses. Elife. 2019 10 09; 8.
-
Bender H, Noyes N, Annis JL, Hitpas A, Mollnow L, Croak K, Kane S, Wagner K, Dow S, Zabel M. PrPC knockdown by liposome-siRNA-peptide complexes (LSPCs) prolongs survival and normal behavior of prion-infected mice immunotolerant to treatment. PLoS One. 2019; 14(7):e0219995.
-
Heineman TC, Cunningham A, Levin M. Understanding the immunology of Shingrix, a recombinant glycoprotein E adjuvanted herpes zoster vaccine. Curr Opin Immunol. 2019 08; 59:42-48.
-
Levin MJ, Weinberg A. Immune responses to zoster vaccines. Hum Vaccin Immunother. 2019; 15(4):772-777.
-
Hu S, Li M, Akkina R. Generation of High-Titer Pseudotyped Lentiviral Vectors. Methods Mol Biol. 2019; 1937:125-134.
-
Cunningham AL, Heineman TC, Lal H, Godeaux O, Chlibek R, Hwang SJ, McElhaney JE, Vesikari T, Andrews C, Choi WS, Esen M, Ikematsu H, Choma MK, Pauksens K, Ravault S, Salaun B, Schwarz TF, Smetana J, Abeele CV, Van den Steen P, Vastiau I, Weckx LY, Levin MJ. Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older. J Infect Dis. 2018 05 05; 217(11):1750-1760.
-
Droho S, Keener ME, Mueller NH. Heparan sulfate mediates cell uptake of aB-crystallin fused to the glycoprotein C cell penetration peptide. Biochim Biophys Acta Mol Cell Res. 2018 Apr; 1865(4):598-604.
-
Gunn BM, Jones JE, Shabman RS, Whitmore AC, Sarkar S, Blevins LK, Morrison TE, Heise MT. Ross River virus envelope glycans contribute to disease through activation of the host complement system. Virology. 2018 02; 515:250-260.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|